Top Markets
Coin of the day
Cell MedX Corp. Cell MedX Corp.

Cell MedX Corp.

CMXC
Rank in Stocks #30404
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing,... Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.
Share Price
$0.41
Last synced: 2024-12-24
Market Cap
$16.96M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Cell MedX Corp. (CMXC)

Category

EPS for Cell MedX Corp. (CMXC)
EPS as of 2026 TTM: 0
According to Cell MedX Corp. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Cell MedX Corp. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors